Pfizer - 46 Year Stock Price History | PFE

Historical daily share prices for Pfizer since 1972 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Pfizer as of August 16, 2018 is 41.42.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $245.020B $52.546B
Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company's diversified global healthcare portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and consumer healthcare products. Pfizer's Animal Health business unit discovers, develops and sells products for the prevention and treatment of diseases in livestock and companion animals. It sells its products to wholesalers, distributors, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, veterinarians, livestock producers, and grocery and convenience stores. Pfizer Inc. is headquartered in New York.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $349.931B 16.72
Novartis AG (NVS) Switzerland $189.637B 16.27
Merck (MRK) United States $181.642B 16.04
AbbVie (ABBV) United States $147.566B 14.42
Novo Nordisk (NVO) Denmark $116.361B 18.60
Eli Lilly (LLY) United States $110.975B 20.54
Sanofi (SNY) France $101.327B 12.82
GlaxoSmithKline (GSK) United Kingdom $100.338B 13.40
Bristol-Myers Squibb (BMY) United States $98.497B 17.83
AstraZeneca (AZN) United Kingdom $97.390B 10.71